Harvard Business Review April 25, 2024
Summary: Drug shortages continue to plague the United States. In many ways, the problem is the result of deficiencies in the current pharma market. But a model for addressing this problem is showing that it isn’t intractable. The company employing this model is Civica Rx, which was established in 2018 by health systems and philanthropies to address shortages of generic sterile injectable drug. This article discusses the elements of its model and its achievements.
...Today's Sponsors
Today's Sponsor